COURTNEY BETHEA: Open Payments
NPI 1538634837 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,807 in 135 payments from 14 companies in 2025. Trend: 2023 $1,638 · 2024 $1,353 · 2025 $1,807
Food & beverage: $1,807
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 64 | $537 |
| Phathom Pharmaceuticals, Inc. | 10 | $222 |
| Janssen Biotech, Inc. | 14 | $201 |
| Regeneron Healthcare Solutions, Inc. | 9 | $181 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $141 |
| Gilead Sciences, Inc. | 5 | $97 |
| Lilly USA, LLC | 5 | $92 |
| Ipsen Biopharmaceuticals, Inc | 4 | $74 |
| GENZYME CORPORATION | 3 | $68 |
| Celltrion USA Inc. | 4 | $58 |
Products named: RINVOQ, DUPIXENT, VOQUEZNA, TREMFYA, ENTYVIO, LINZESS, CREON, OMVOH.
Industry payments across AR — which companies pay providers there.
